Skip to main content
Signal8

NORTHWEST BIOTHERAPEUTICS INC (NWBO) Form 8-K — Oct 30, 2026

$NWBOForm 8-KItems 1.01, 2.03Filed Oct 30, 2026, 4:10 PM ET0001104659-26-120669Original filing

Northwest Biotherapeutics entered into a $5,505,000 commercial loan agreement with Streeterville Capital, LLC on October 26, 2026, with proceeds earmarked for ongoing business operations. The loan carries an 8% annual interest rate with a ten percent original issue discount, matures in 22 months, and requires no repayments for the first 8 months before amortizing in 14 monthly installments of principal at 110% of the pro rata amount plus interest starting June 26, 2027.

Key figures

Debt Amount
5505000
Interest Rate
8
Maturity Date
22-month maturity from October 26, 2026
Amortization
14 equal monthly installments of principal at 110% of pro rata amount plus interest, beginning June 26, 2027
Prepayment charge
10%
Original issue discount
10%
Repayment holiday months
8

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.